Halaven (Eisai Inc.)
Welcome to the PulseAid listing for the Halaven drug offered from Eisai Inc.. This Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Eisai Inc. |
| NON-PROPRIETARY NAME: | eribulin mesylate |
| SUBSTANCE NAME: | ERIBULIN MESYLATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Microtubule Inhibition [PE],Microtubule Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-11-15 |
| END MARKETING DATE: | 0000-00-00 |
Halaven HUMAN PRESCRIPTION DRUG Details:
| Item Description | Halaven from Eisai Inc. |
| LABELER NAME: | Eisai Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 0.5(mg/mL) |
| START MARKETING DATE: | 2010-11-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 62856-389_96f011d6-6028-4b63-a742-658d45404f05 |
| PRODUCT NDC: | 62856-389 |
| APPLICATION NUMBER: | NDA201532 |
Other ERIBULIN MESYLATE Pharmaceutical Manufacturers / Labelers:
